Ong, Voon

Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults

Sandison, T., Ong, V., Lee, J., & Thye, D. (2017) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityAntibiotics Pharmacokinetics and Efficacy

Cited by 161

CD101: a novel long-acting echinocandin

Zhao, Y., Perez, W. B., Jiménez‐Ortigosa, C., Hough, G., Locke, J. B., Ong, V., Bartizal, K., & Perlin, D. S. (2016) · Cellular Microbiology

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 81

Pharmacological basis of CD101 efficacy: exposure shape matters

Lakota, E. A., Bader, J. C., Ong, V., Bartizal, K., Miesel, L., Andes, D. R., Bhavnani, S. M., Rubino, C. M., Ambrose, P. G., & Lepak, A. J. (2017) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityAntibiotics Pharmacokinetics and Efficacy

Cited by 40

982. Effect of hepatic impairment on the safety and pharmacokinetics of rezafungin

Huguet, J., Ong, V., Sandison, T., Melara, R. M., Marbury, T. C., Jandourek, A., & Flanagan, S. (2021) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityAntibiotics Pharmacokinetics and Efficacy

Cited by 4